PITTSBURGH, Feb. 08, 2021 (GLOBE NEWSWIRE) -- II‐VI Incorporated (Nasdaq: IIVI), a leading provider of semiconductor lasers and micro-optics for consumer electronics, today announced its ...
Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Expected to Initiate in 2013; One Trial Already Underway Boulder, Colo., (June 3, 2013) – Two Array BioPharma-invented MEK inhibitors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results